Lisata Therapeutics Inc (LSTA)

New Form 8-K - LISATA THERAPEUTICS, INC. Filed: 2025-06-17 AccNo: 0000320017-25-000039 Size: 11 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Syra Health Corp (SYRA)

New Form 8-K - Syra Health Corp Filed: 2025-06-17 AccNo: 0001641172-25-015349 Size: 197 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

IGC Pharma Inc (IGC)

New Form 8-K - IGC Pharma, Inc. Filed: 2025-06-17 AccNo: 0001185185-25-000657 Size: 133 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Microbot Medical Inc (MBOT)

New Form 8-K - Microbot Medical Inc. Filed: 2025-06-17 AccNo: 0001641172-25-015345 Size: 236 KB Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Lixte Biotechnology Holdings Inc. (LIXTW)

New Form 8-K - LIXTE BIOTECHNOLOGY HOLDINGS, INC. Filed: 2025-06-17 AccNo: 0001641172-25-015346 Size: 391 KB Item 1.01: Entry into a Material Definitive Agreement Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits